Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis

NCT07202598 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

10

Enrollment

NIH

Sponsor class

Conditions

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis

Interventions

DRUG: Emapalumab

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)